Research Paper Volume 15, Issue 13 pp 6302—6330
Clinical significance, tumor immune landscape and immunotherapy responses of ADAR in pan-cancer and its association with proliferation and metastasis of bladder cancer
Figure 2. Mutational landscape of ADAR in pan-cancer. (A) The genetic alteration status of ADAR in pan-cancer through the cBioPortal database. (B) The types, loci, and case information of ADAR genetic alterations. (C) The 3D structure shows the S629F mutation site on ADAR protein. (D) A dot plot of ADAR gene alterations in pan-cancer. (E) Survival analysis between the altered and unaltered groups.